Skip to main content

Advertisement

Log in

Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

There is a paucity of information on extrahepatic autoimmune (EHA) conditions associated with primary biliary cirrhosis (PBC) and on the impact of EHA conditions on PBC patients’ survival. Our goal was to assess the association between PBC and other autoimmune diseases and the impact of EHA conditions on the natural history of PBC. We took advantage of 361 consecutive PBC patients enrolled between 1975 and 2012 (22 males, 339 females; mean follow-up 8 ± 6.9 years). Any associated EHA conditions, PBC histological stage at diagnosis, biochemical data, physiological history, and extrahepatic malignancies developing during the follow-up were recorded. Survival was analyzed by means of Kaplan-Meier curves. Importantly, 221 patients (61.2 %) had at least one EHA conditions: 45 patients (20.4 %) had Hashimoto thyroiditis; 7 (3.2 %) had Graves’ thyroiditis; 65 (29.4 %) had Raynaud’s phenomenon; 124 (56.1 %) had Sjogren’s syndrome; 8 (3.6 %) had systemic lupus erythematosus; 22 (9.9 %) had scleroderma; 22 (9.9 %) had rheumatoid arthritis; 18 (8.1 %) had cutaneous autoimmune diseases; 8 (3.6 %) had vasculitis; 5 (1.4 %) had celiac disease; and 25 (13.1 %) had other EHA conditions. The proportion of patients with associated EHA conditions enrolled during representative periods (1975–1980, 1981–1990, 1991–2000, 2001–2010, 2011–2012) remained stable. No differences emerged between patients with versus without EHA conditions in terms of mean age at PBC diagnosis, antimitochondrial antibody (AMA), or antinuclear antibody (ANA) positivity, histological stage at diagnosis, smoking habits, alcohol consumption, or BMI >25. Multiple logistic regression analysis showed that only female gender was significantly associated with positivity for EHA conditions (OR 4.8; 95 % CI 1.6–13.7, p = 0.004). The mean survival after the diagnosis of PBC was much the same in patients with and without EHA conditions. In conclusion, EHA conditions are often associated with PBC, especially in female patients, but they do not reduce patient survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Nguyen DL, Juran BD, Lazaridis KN (2010) Primary biliary cirrhosis. Best Pract Res Clin Gastroenterol 24:647–654

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Teufel A, Weinmann A, Kahaly GJ et al (2010) Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 44:208–213

    Article  CAS  PubMed  Google Scholar 

  3. Trivedi PJ, Hirschfield GM (2012) Review article: overlap syndromes and autoimmune liver disease. Aliment Pharmacol Ther 36:517–533

    Article  CAS  PubMed  Google Scholar 

  4. Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E (2011) Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 54:374–385

    Article  PubMed  Google Scholar 

  5. Wang L, Zhang FC, Chen H et al (2013) Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study. World J Gastroenterol 19:5131–5137

    Article  PubMed Central  PubMed  Google Scholar 

  6. Ando Y, Yang GX, Kenny TP et al (2013) Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse. J Autoimmun 41:111–119

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Ando Y, Yang GX, Tsuda M et al (2012) The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice. Hepatology 56:1418–1426

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Chen RC, Naiyanetr P, Shu SA et al (2013) Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology 57:1498–1508

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Jin Q, Moritoki Y, Lleo A et al (2012) Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis. Hepatology 55:1495–1506

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Leung PS, Wang J, Naiyanetr P et al (2013) Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun 41:79–86

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Lleo A, Liao J, Invernizzi P et al (2012) Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 55:153–160

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Podda M, Selmi C, Lleo A, Moroni L, Invernizzi P (2013) The limitations and hidden gems of the epidemiology of primary biliary cirrhosis. J Autoimmun 46:81–87

    Article  PubMed  Google Scholar 

  13. Takahashi T, Miura T, Nakamura J et al (2012) Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis. Hepatology 55:846–855

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Tanaka H, Yang GX, Iwakoshi N et al (2013) Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol 174:364–371

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Tsuda M, Zhang W, Yang GX et al (2013) Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFbeta receptor type II mice. Hepatology 57:806–816

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Wang Q, Selmi C, Zhou X et al (2013) Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 41:140–145

    Article  PubMed  Google Scholar 

  17. You Z, Wang Q, Bian Z et al (2012) The immunopathology of liver granulomas in primary biliary cirrhosis. J Autoimmun 39:216–221

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Floreani A, Caroli D, Variola A et al (2011) A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int 31:361–368

    Article  PubMed  Google Scholar 

  19. Scheuer P (1967) Primary biliary cirrhosis. Proc R Soc Med 60:1257–1260

    PubMed Central  CAS  PubMed  Google Scholar 

  20. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  CAS  PubMed  Google Scholar 

  21. LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205

    CAS  PubMed  Google Scholar 

  22. Petri M, Orbai AM, Alarcon GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686

    Article  PubMed Central  PubMed  Google Scholar 

  23. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347

    Article  CAS  PubMed  Google Scholar 

  24. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A (1989) Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 10:1–7

    Article  CAS  PubMed  Google Scholar 

  25. Conn HO, Leevy CM, Vlahcevic ZR et al (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 72:573–583

    CAS  PubMed  Google Scholar 

  26. Alarcon-Segovia D, Diaz-Jouanen E, Fishbein E (1973) Features of Sjogren’s syndrome in primary biliary cirrhosis. Ann Intern Med 79:31–36

    Article  CAS  PubMed  Google Scholar 

  27. Crowe JP, Christensen E, Butler J et al (1980) Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 78:1437–1441

    CAS  PubMed  Google Scholar 

  28. Golding PL, Bown R, Mason AM, Taylor E (1970) “Sicca complex” in liver disease. Br Med J 4:340–342

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Tsianos EV, Hoofnagle JH, Fox PC et al (1990) Sjogren’s syndrome in patients with primary biliary cirrhosis. Hepatology 11:730–734

    Article  CAS  PubMed  Google Scholar 

  30. Fox RI (2005) Sjogren’s syndrome. Lancet 366:321–331

    Article  CAS  PubMed  Google Scholar 

  31. Selmi C, Meroni PL, Gershwin ME (2012) Primary biliary cirrhosis and Sjogren’s syndrome: autoimmune epithelitis. J Autoimmun 39:34–42

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Rigamonti C, Shand LM, Feudjo M et al (2006) Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 55:388–394

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Floreani A, Betterle C, Baragiotta A et al (2002) Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 34:258–261

    Article  CAS  PubMed  Google Scholar 

  34. Lawson A, West J, Aithal GP, Logan RF (2005) Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Aliment Pharmacol Ther 21:401–405

    Article  CAS  PubMed  Google Scholar 

  35. Kubo S, Iwata S, Saito K, Tanaka Y (2011) Successful treatment of primary biliary cirrhosis with etanercept in a patient with rheumatoid arthritis. Joint Bone Spine 78:535–536

    Article  PubMed  Google Scholar 

  36. Spadaro A, Scrivo R, Riccieri V, Valesini G (2008) Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 75:87–89

    Article  PubMed  Google Scholar 

  37. Imam MH, Talwalkar JA, Lindor KD (2013) Clinical management of autoimmune biliary diseases. J Autoimmun 46:88–96

    Article  CAS  PubMed  Google Scholar 

Download references

Declaration of Funding Source

This work was partially supported by a grant from the University of Padova.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Annarosa Floreani.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Floreani, A., Franceschet, I., Cazzagon, N. et al. Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. Clinic Rev Allerg Immunol 48, 192–197 (2015). https://doi.org/10.1007/s12016-014-8427-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-014-8427-x

Keywords

Navigation